Abigail Pothen, APRN
Women's Health · Columbia, SCNPI 1780217513
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,181 of the $3,410 with a category attached, or 63.9%. 16 manufacturers reported payments, led by Medtronic at 60.0% of the total. Reporting peaked in 2024 at $1,882 and has fallen 72.7% since, to $515 in 2025. Among women's health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $42.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Astellas Pharma US Inc$384
- AbbVie$353
- Sumitomo Pharma America, Inc.$294
- Progenics Pharmaceuticals, Inc.$65
- Pfizer$44
- plus $226 from 10 others
What the payments were for
- Travel & lodging$89326%
- Food & beverage$2,18164%
- Education$33710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 29 | $2,046 |
| Astellas Pharma US Inc | 8 | $384 |
| AbbVie | 16 | $353 |
| Sumitomo Pharma America, Inc. | 11 | $294 |
| Progenics Pharmaceuticals, Inc. | 3 | $65 |
| Pfizer | 2 | $44 |
| Ambu Inc. | 2 | $42 |
| Tolmar, Inc. | 1 | $29 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $27 |
| Coloplast | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| 180 Medical, Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Olympus America Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,235
How this compares
$3,410 in reported general payments places this provider in the 95th percentile of 62 women's health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 80 | $62,228 |
| MyrbetriqMirabegron | 98 | $54,101 |
| Estradiol | 127 | $7,951 |
| EstringEstradiol | 14 | $7,368 |
| Mirabegron ErMirabegron | 11 | $5,152 |
| Solifenacin Succinate | 19 | $1,557 |
| Clobetasol Propionate | 13 | $429 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $382 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $127 |
| Cephalexin | 17 | $75 |
| Fluconazole | 13 | $72 |
| Tamsulosin Hcl | 17 | $70 |
| Ciprofloxacin Hcl | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $294 | $62,22880 claims |
| Astellas Pharma US IncMyrbetriq | $384 | $54,10198 claims |
| PfizerEstring | $44 | $7,36814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 62 women's health providers in South Carolina.
Other women's health in Columbia
- Kahlil DemonbreunColumbia$32K
- Stacy FordColumbia$22
- Christine McMahanAnderson$3K
- Kathryn OdonaldConway$2K
- Jacqueline MooreCharleston$2K
- Erin WilkinsCharleston$2K
- Amanda RubyConway$2K
- Karen ThompsonMyrtle Beach$1K
- Danielle AndrewsGreenville$1K
- Kim ShapiroSummerville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.